vs
Pediatrix Medical Group, Inc.（MD）与PROGRESS SOFTWARE CORP（PRGS）财务数据对比。点击上方公司名可切换其他公司
Pediatrix Medical Group, Inc.的季度营收约是PROGRESS SOFTWARE CORP的2.0倍（$493.8M vs $252.7M），PROGRESS SOFTWARE CORP净利率更高（10.2% vs 6.8%，领先3.4%），PROGRESS SOFTWARE CORP同比增速更快（17.5% vs -1.7%），过去两年PROGRESS SOFTWARE CORP的营收复合增速更高（17.0% vs -0.1%）
Pediatrix Medical Group是美国领先的专科医疗服务提供商，核心业务覆盖母胎医学、新生儿科、儿科心脏病学等儿科亚专科领域，与美国各地医疗机构合作，为女性、新生儿及儿童提供循证专科医疗服务。
Progress Software是全球领先的企业级软件服务商，主营应用开发平台、数据连接工具、数字体验解决方案等产品，服务覆盖金融、医疗、制造、零售等多行业的全球企业客户，助力客户搭建高性能可扩展的业务应用，提升运营效率。
MD vs PRGS — 直观对比
营收规模更大
MD
是对方的2.0倍
$252.7M
营收增速更快
PRGS
高出19.3%
-1.7%
净利率更高
PRGS
高出3.4%
6.8%
两年增速更快
PRGS
近两年复合增速
-0.1%
损益表 — Q4 FY2025 vs Q4 FY2025
| 指标 | | |
|---|---|---|
| 营收 | $493.8M | $252.7M |
| 净利润 | $33.7M | $25.7M |
| 毛利率 | — | 81.6% |
| 营业利润率 | 9.9% | 15.2% |
| 净利率 | 6.8% | 10.2% |
| 营收同比 | -1.7% | 17.5% |
| 净利润同比 | 10.5% | 2144.6% |
| 每股收益（稀释后） | $0.40 | $0.59 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收MDPRGS
| Q4 25 | $493.8M | $252.7M | ||
| Q3 25 | $492.9M | $249.8M | ||
| Q2 25 | $468.8M | $237.4M | ||
| Q1 25 | $458.4M | $238.0M | ||
| Q4 24 | $502.4M | $215.0M | ||
| Q3 24 | $511.2M | $178.7M | ||
| Q2 24 | $504.3M | $175.1M | ||
| Q1 24 | $495.1M | $184.7M |
净利润MDPRGS
| Q4 25 | $33.7M | $25.7M | ||
| Q3 25 | $71.7M | $19.4M | ||
| Q2 25 | $39.3M | $17.0M | ||
| Q1 25 | $20.7M | $10.9M | ||
| Q4 24 | $30.5M | $1.1M | ||
| Q3 24 | $19.4M | $28.5M | ||
| Q2 24 | $-153.0M | $16.2M | ||
| Q1 24 | $4.0M | $22.6M |
毛利率MDPRGS
| Q4 25 | — | 81.6% | ||
| Q3 25 | — | 81.0% | ||
| Q2 25 | — | 80.1% | ||
| Q1 25 | — | 80.6% | ||
| Q4 24 | — | 83.0% | ||
| Q3 24 | — | 83.7% | ||
| Q2 24 | — | 81.7% | ||
| Q1 24 | — | 82.2% |
营业利润率MDPRGS
| Q4 25 | 9.9% | 15.2% | ||
| Q3 25 | 13.8% | 17.6% | ||
| Q2 25 | 12.8% | 16.3% | ||
| Q1 25 | 7.0% | 13.6% | ||
| Q4 24 | 7.8% | 10.0% | ||
| Q3 24 | 6.6% | 22.6% | ||
| Q2 24 | -31.3% | 15.5% | ||
| Q1 24 | 3.2% | 19.0% |
净利率MDPRGS
| Q4 25 | 6.8% | 10.2% | ||
| Q3 25 | 14.5% | 7.8% | ||
| Q2 25 | 8.4% | 7.2% | ||
| Q1 25 | 4.5% | 4.6% | ||
| Q4 24 | 6.1% | 0.5% | ||
| Q3 24 | 3.8% | 15.9% | ||
| Q2 24 | -30.3% | 9.2% | ||
| Q1 24 | 0.8% | 12.3% |
每股收益（稀释后）MDPRGS
| Q4 25 | $0.40 | $0.59 | ||
| Q3 25 | $0.84 | $0.44 | ||
| Q2 25 | $0.46 | $0.39 | ||
| Q1 25 | $0.24 | $0.24 | ||
| Q4 24 | $0.37 | $0.01 | ||
| Q3 24 | $0.23 | $0.65 | ||
| Q2 24 | $-1.84 | $0.37 | ||
| Q1 24 | $0.05 | $0.51 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $375.2M | $94.8M |
| 总债务越低越好 | $570.5M | $1.4B |
| 股东权益账面价值 | $865.9M | $478.3M |
| 总资产 | $2.2B | $2.5B |
| 负债/权益比越低杠杆越低 | 0.66× | 2.93× |
8季度趋势，按日历期对齐
现金及短期投资MDPRGS
| Q4 25 | $375.2M | $94.8M | ||
| Q3 25 | $340.1M | $99.0M | ||
| Q2 25 | $224.7M | $102.0M | ||
| Q1 25 | $99.0M | $124.2M | ||
| Q4 24 | $229.9M | $118.1M | ||
| Q3 24 | $103.8M | $232.7M | ||
| Q2 24 | $19.4M | $190.4M | ||
| Q1 24 | $8.0M | $133.2M |
总债务MDPRGS
| Q4 25 | $570.5M | $1.4B | ||
| Q3 25 | $577.2M | $1.4B | ||
| Q2 25 | $583.9M | $1.5B | ||
| Q1 25 | $590.5M | $1.5B | ||
| Q4 24 | $597.1M | $1.5B | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
股东权益MDPRGS
| Q4 25 | $865.9M | $478.3M | ||
| Q3 25 | $890.7M | $477.7M | ||
| Q2 25 | $833.8M | $452.7M | ||
| Q1 25 | $789.2M | $431.8M | ||
| Q4 24 | $764.9M | $438.8M | ||
| Q3 24 | $732.5M | $425.6M | ||
| Q2 24 | $706.5M | $401.7M | ||
| Q1 24 | $856.2M | $461.7M |
总资产MDPRGS
| Q4 25 | $2.2B | $2.5B | ||
| Q3 25 | $2.2B | $2.4B | ||
| Q2 25 | $2.1B | $2.4B | ||
| Q1 25 | $2.0B | $2.5B | ||
| Q4 24 | $2.2B | $2.5B | ||
| Q3 24 | $2.1B | $1.6B | ||
| Q2 24 | $2.0B | $1.6B | ||
| Q1 24 | $2.2B | $1.5B |
负债/权益比MDPRGS
| Q4 25 | 0.66× | 2.93× | ||
| Q3 25 | 0.65× | 2.97× | ||
| Q2 25 | 0.70× | 3.22× | ||
| Q1 25 | 0.75× | 3.50× | ||
| Q4 24 | 0.78× | 3.48× | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $114.1M | $62.8M |
| 自由现金流经营现金流 - 资本支出 | — | $59.9M |
| 自由现金流率自由现金流/营收 | — | 23.7% |
| 资本支出强度资本支出/营收 | — | 1.1% |
| 现金转化率经营现金流/净利润 | 3.39× | 2.44× |
| 过去12个月自由现金流最近4个季度 | — | $229.5M |
8季度趋势，按日历期对齐
经营现金流MDPRGS
| Q4 25 | $114.1M | $62.8M | ||
| Q3 25 | $137.3M | $73.4M | ||
| Q2 25 | $137.2M | $30.0M | ||
| Q1 25 | $-117.5M | $68.9M | ||
| Q4 24 | $133.0M | $19.7M | ||
| Q3 24 | $91.8M | $57.7M | ||
| Q2 24 | $107.0M | $63.7M | ||
| Q1 24 | $-125.2M | $70.5M |
自由现金流MDPRGS
| Q4 25 | — | $59.9M | ||
| Q3 25 | — | $72.4M | ||
| Q2 25 | — | $29.5M | ||
| Q1 25 | — | $67.7M | ||
| Q4 24 | — | $16.8M | ||
| Q3 24 | — | $56.6M | ||
| Q2 24 | — | $62.7M | ||
| Q1 24 | — | $70.2M |
自由现金流率MDPRGS
| Q4 25 | — | 23.7% | ||
| Q3 25 | — | 29.0% | ||
| Q2 25 | — | 12.4% | ||
| Q1 25 | — | 28.4% | ||
| Q4 24 | — | 7.8% | ||
| Q3 24 | — | 31.7% | ||
| Q2 24 | — | 35.8% | ||
| Q1 24 | — | 38.0% |
资本支出强度MDPRGS
| Q4 25 | — | 1.1% | ||
| Q3 25 | — | 0.4% | ||
| Q2 25 | — | 0.2% | ||
| Q1 25 | — | 0.5% | ||
| Q4 24 | — | 1.3% | ||
| Q3 24 | — | 0.6% | ||
| Q2 24 | — | 0.5% | ||
| Q1 24 | — | 0.2% |
现金转化率MDPRGS
| Q4 25 | 3.39× | 2.44× | ||
| Q3 25 | 1.91× | 3.78× | ||
| Q2 25 | 3.49× | 1.76× | ||
| Q1 25 | -5.66× | 6.30× | ||
| Q4 24 | 4.36× | 17.13× | ||
| Q3 24 | 4.72× | 2.03× | ||
| Q2 24 | — | 3.93× | ||
| Q1 24 | -31.03× | 3.11× |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
MD
| Health Care Patient Service | $421.6M | 85% |
| Hospitals Contracts | $70.0M | 14% |
| Other | $2.2M | 0% |
PRGS
| Maintenanceand Services | $187.5M | 74% |
| Share File Acquisition | $67.5M | 27% |
